SPRY Operating Cash Flow (Statement)
Ars Pharmaceuticals Inc · Operating Cash Flow (Statement)
SPRY Operating Cash Flow (Statement)
Latest reported-$196.41Mperiod ending
SPRY Cash from Operations (-$16.88M → -$196.41M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SPRY operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -170,866,000 | |
| 13,548,000 | |
| -59,266,000 | |
| -40,078,000 | |
| -17,561,000 | |
| 9,071,000 | |
| -18,898,000 | |
| -16,875,000 |